Documentos relacionados

1. [Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
2. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
3. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
4. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
5. Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
6. Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
7. Sitosterolemia: opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father.
8. Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
9. Cost effectiveness of cholesterol-lowering therapy in The Netherlands. Simvastatin versus cholestyramine.
10. Current perspectives on statins.